Loading…
Samsung E&A secured a 518.6 billion-won ($354.2 million) contract to build a biopharmaceutical raw material production and research facility in Songdo, Incheon, for Sartorius AG. The plant will manufacture single-use bioprocessing bags and pharmaceutical membrane filters. Completion is scheduled for 2027.